Q1 2025 Management View CEO Joe Papa highlighted significant progress in Emergent's multiyear turnaround plan, focusing on stabilizing operations, streamlining costs, and driving sustainable growth.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...